ICER Hosts Meeting on Migraine Treatments
The Institute for Clinical and Economic Review (ICER) hosted a public meeting last week to discuss new treatments for migraines. [...]
Podcast Highlights MS Drug Prices, Football Injuries
A recent Neurology Podcast features a discussion with Dr. Daniel Hartung about his study on drug prices for multiple sclerosis. [...]
Report Puts Spotlight on Pharma Transparency
FirstWord Pharma in its "Pricing Transparency in Pharma" report explores the rising demand for increased transparency. The report highlights 10 [...]
Pearson: Patient Engagement is Key to Fixing ‘Broken’ System
The key first step to fixing the "broken" U.S. health care system is to overhaul how organizations engage with patients, [...]
Patient-Preference Data in Medical Devices to Take Center Stage at ISPOR-FDA Summit
An upcoming summit hosted by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in conjunction with the Food and [...]
PhRMA Announces HEOR Funding Opportunities
The PhRMA Foundation announced it is accepting applications for up to $100,000 in fellowships and grants for health outcomes research. [...]
Biogen, UPMC Health Plan Contract Links PROs to Drug Reimbursement for Multiple Sclerosis
Biogen and UPMC Health Plan have signed off on a value-based contract that would link reimbursement to patient-reported outcomes for [...]
IQWiG: Patient Registry Data can be Used in Benefit Assessments
High-quality data from patient registries can be utilized for added benefit assessments for new drugs, the Institute for Quality and [...]
Pink Sheet Report Looks at Influence of NHS England, NICE
A recent analysis by The Pink Sheet dives into the influence of two drug pricing forces in the U.K.: the [...]
Survey Finds Increasing Interest in Patient-Reported Data from Outcomes-Based Contracts
A new survey conducted by Avalere Health suggests rising interest among payers to generate patient-reported data through outcomes-based contracts, according [...]
Report: Gene Therapies Could Add $45B to Health Costs
A new report from CVS Health suggests gene therapies could add an additional $45 billion to health care costs over [...]
ISPOR Conducting Survey on Current Understanding of COA Terms
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Clinical Outcome Assessment (COA) Special Interest Group is seeking member input [...]
FDA Pushes Back Deadline for Feedback on Drug Effectiveness Evidence Guide
The Food and Drug Administration (FDA) announced last week that it had extended the deadline for input on its draft [...]
GMI: HEOR Market to Hit $1.7B by 2026
The health economics and outcomes research (HEOR) market will exceed $1.7 billion by 2026, Global Market Insights suggests in a [...]
A Look at California’s Plan to Make Generic Drugs
A recent report by The Sacramento Bee takes an in-depth look at California's plan to manufacture its own generic drugs [...]
SDOH Vendors Look to Build Pathways to Key Resources
New specialized vendors are taking action with social determinants of health by developing new software solutions that aim to bridge [...]
Dems Pivot to Insulin, Illinois Caps Insulin Prices
Democratic presidential candidates during a campaign stop in Iowa made clear their frustration over U.S. insulin prices, STAT reports. During [...]
NPC’s Leonard Outlines ‘Wish List’ for Health Sector
National Pharmaceutical Council President and CEO Dan Leonard in an article published on Chain Drug Review outlines his wish list [...]
Epic Chief Urges Hospital CEOs Oppose Proposal
Epic CEO Judy Faulkner in an email sent to hospital CEOs and presidents urged recipients to rally behind the medical [...]
Systematic Review Experts Offer Tips for Full-Text Reference Retrieval
A recent Evidence Partners blog post features key tips for full-text reference procurement from two systematic review experts. The author, [...]
ICER Outlines Planned Review of Hemophilia A Treatments
The Institute for Clinical and Economic Review (ICER) released a draft scoping document outlining its planned review of two treatments [...]
Blog Post Highlights AMCP’s Partnership Forum
A recent National Pharmaceutical Council (NPC) blog post highlights the Academy of Managed Care Pharmacy (AMCP) Partnership Forum, "Optimizing Prior [...]
Supreme Court to Hear Lawsuit Challenging State’s Authority to Regulate PBMs
The Supreme Court is set to hear a lawsuit filed by the Pharmaceutical Care Management Association which challenges an Arkansas [...]
Value in Health Publishes Themed Section on HTA
Value in Health announced the publication of a series of articles that delve into how health technology assessment (HTA) is [...]
Is California Planning to Sell Its Own Generic Drugs?
California's Democratic Governor Gavin Newsom earlier this month proposed his potential solution to reduce drug prices: have the state manufacture [...]